Kinetics of Inhibition of Endogenous Human Immunodeficiency Virus Type 1 Reverse Transcription by 2',3'-Dideoxynucleoside 5'-

Zeger DebyserS; Anne‐Mieke Vandamme; Rudi Pauwels; Masanori BabaO; Jan Desmyter; De Clercq Erik

Back

Kinetics of Inhibition of Endogenous Human Immunodeficiency Virus Type 1 Reverse Transcription by 2',3'-Dideoxynucleoside 5'-

Article 1992 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1993

Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.

Zeger Debyser, K De Vreese, P P Knops-Gerrits, Veerle Baekelandt, Ramagauri Bhikhabhai, B. Strandberg, Rudi Pauwels, Jozef Anné, Jan Desmyter, De Clercq Erik

Article2007

Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives

Miguel Stevens, Jan Balzarini, Irene M. Lagoja, Bernard Noppen, Katrien O. François, Arthur Van Aerschot, Piet Herdewijn, De Clercq Erik, Christophe Pannecouque

Article1989

2',3'-Dideoxynucleoside analogues as inhibitors of human immunodeficiency virus

Piet Herdewijn, Arthur Van Aerschot, Jan Balzarini, De Clercq Erik

Article2002

Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives

Wim Pluymers, Godwin C. G. Pais, Bénédicte Van Maele, Christophe Pannecouque, Valery Fikkert, Terrence R. Burke, De Clercq Erik, Myriam Witvrouw, Nouri Neamati, Zeger Debyser

Article1992

Allosteric inhibition of endogenous HIV-1 reverse transcription by TIBO derivatives

Zeger Debyser, Anne‐Mieke Vandamme, Rudi Pauwels, Jan Desmyter, De Clercq Erik